Literature DB >> 22415492

[Calcimimetics: no competition for surgery in primary hyperparathyroidism].

K Lorenz1.   

Abstract

Entities:  

Year:  2012        PMID： 22415492     DOI： 10.1007/s00104-012-2289-7

Source DB:  PubMed          Journal:  Chirurg        ISSN： 0009-4722            Impact factor:   0.955


× No keyword cloud information.
  5 in total

1.  Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop.

Authors:  John P Bilezikian; Aliya A Khan; John T Potts
Journal:  J Clin Endocrinol Metab       Date:  2009-02       Impact factor: 5.958

Review 2.  Current evidence for recommendation of surgery, medical treatment and vitamin D repletion in mild primary hyperparathyroidism.

Authors:  Jens Bollerslev; Claudio Marcocci; Manuel Sosa; Jörgen Nordenström; Roger Bouillon; Leif Mosekilde
Journal:  Eur J Endocrinol       Date:  2011-09-29       Impact factor: 6.664

Review 3.  Cinacalcet for the treatment of primary hyperparathyroidism.

Authors:  Melanie L Dillon; Lawrence A Frazee
Journal:  Am J Ther       Date:  2011-07       Impact factor: 2.688

4.  Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993-2001: an update on the changing epidemiology of the disease.

Authors:  Robert A Wermers; Sundeep Khosla; Elizabeth J Atkinson; Sara J Achenbach; Ann L Oberg; Clive S Grant; L Joseph Melton
Journal:  J Bone Miner Res       Date:  2005-09-19       Impact factor: 6.741

Review 5.  NIH conference. Diagnosis and management of asymptomatic primary hyperparathyroidism: consensus development conference statement.

Authors: 
Journal:  Ann Intern Med       Date:  1991-04-01       Impact factor: 25.391
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.